首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)
Authors:Joseph Jankovic  Charles H Adler  P David Charles  Cynthia Comella  Mark Stacy  Marc Schwartz  Susan M Sutch  Mitchell F Brin and Spyridon Papapetropoulos
Institution:(1) Department of Neurology, Baylor College of Medicine, Houston, TX, USA;(2) Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA;(3) Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA;(4) Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA;(5) Department of Neurology, Duke University Medical Center, Durham, NC, USA;(6) MedNet Solutions, Inc., Biostatistics, Minnetonka, MN, USA;(7) UBC-Envision Group, Scientific Solutions, Philadelphia, PA, USA;(8) Global Drug Development, Allergan, Inc., Irvine, CA, USA;(9) University of California, School of Medicine, Irvine, CA, USA;(10) Allergan, Inc., Medical Affairs, Irvine, CA, USA;(11) University of Miami, Miller School of Medicine, Miami, FL, USA
Abstract:

Background  

A registry of patients with cervical dystonia (Cervical Dystonia Patient Registry for Observation of onaBotulinumtoxinA Efficacy CD PROBE]) was initiated to capture data regarding physician practices and patient outcomes with onabotulinumtoxinA (BOTOX?, Allergan, Inc., Irvine, CA, USA). Methods and baseline demographics from an interim analysis are provided.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号